FDA NDC Directory · JSON-LD · Markdown

Praluent

NDC 61755-021 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namealirocumab
Labeler / ManufacturerRegeneron Pharmaceuticals, Inc.
Marketing categoryBiologic License Application · App BLA125559
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsALIROCUMAB (150 mg/mL)
Marketing started20201201
Package count3

External sources

Source: openFDA. Public-domain (CC0).